#Glenmark Pharmaceuticals on Tuesday announced its interim data of 503 patients from its ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, '#Glenmark Pharmaceuticals on Tuesday announced its interim data of 503 patients from its Post Marketing Surveillance (PMS) study on #Favipiravir in India. Photo: IANS (File)'
#Glenmark Pharmaceuticals on Tuesday announced its interim data of 503 patients from its Post Marketing Surveillance (PMS) study on #Favipiravir in India.
Photo: IANS (File) pic.twitter.com/LTcdh73NxU— IANS Tweets (@ians_india) June 8, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Jun 08, 2021 07:42 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
